Clinical Trial Update: A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC) [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating rsCD4 in combination with AZT for HIV infection in patients with AIDS or AIDS-related complex has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immune Deficiency Syndrome
• Aids-related Complex
• HIV Infection

Drugs mentioned

• AZT (zidovudine)
• rsCD4 (recombinant soluble CD4)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: TERMINATED